Publication | Open Access
Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin
128
Citations
33
References
2005
Year
Rad51 siRNA could enhance the sensitivity to CDDP in cancer cells both in vitro and in vivo. Our results suggest that the combination of CDDP and Rad51 siRNA will be an effective anti-cancer protocol.
| Year | Citations | |
|---|---|---|
Page 1
Page 1